Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.880
+0.050 (2.73%)
At close: Sep 17, 2025, 4:00 PM EDT
1.880
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:10 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $70.56 million as of September 17, 2025. Its market cap has decreased by -36.74% in one year.
Market Cap
70.56M
Enterprise Value
-93.32M
1-Year Change
-36.74%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $70.56M, a decrease of -87.46%. That is a compound annual growth rate of -72.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 68.69M | -49.16% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |